WO2021222964A3 - Complexes immunogènes et leurs procédés de production et d'utilisation - Google Patents

Complexes immunogènes et leurs procédés de production et d'utilisation Download PDF

Info

Publication number
WO2021222964A3
WO2021222964A3 PCT/AT2021/060160 AT2021060160W WO2021222964A3 WO 2021222964 A3 WO2021222964 A3 WO 2021222964A3 AT 2021060160 W AT2021060160 W AT 2021060160W WO 2021222964 A3 WO2021222964 A3 WO 2021222964A3
Authority
WO
WIPO (PCT)
Prior art keywords
immunogenic complexes
producing
methods
same
complexes
Prior art date
Application number
PCT/AT2021/060160
Other languages
English (en)
Other versions
WO2021222964A2 (fr
Inventor
Alireza ESLAMIAN
Martin SCHIFKO
Original Assignee
Ess Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ess Holding Gmbh filed Critical Ess Holding Gmbh
Publication of WO2021222964A2 publication Critical patent/WO2021222964A2/fr
Publication of WO2021222964A3 publication Critical patent/WO2021222964A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un procédé de formation de complexes immunogènes, en particulier un procédé de revêtement d'agents pathogènes ou de fragments de ceux-ci avec de la hMBL ou des parties de ceux-ci. En outre, l'invention concerne lesdits complexes immunogènes, des compositions pharmaceutiques comprenant lesdits complexes immunogènes, en particulier des vaccins comprenant lesdits complexes immunogènes, et l'utilisation des complexes immunogènes et des compositions pharmaceutiques.
PCT/AT2021/060160 2020-05-07 2021-05-07 Complexes immunogènes et leurs procédés de production et d'utilisation WO2021222964A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA50394/2020 2020-05-07
AT503942020 2020-05-07

Publications (2)

Publication Number Publication Date
WO2021222964A2 WO2021222964A2 (fr) 2021-11-11
WO2021222964A3 true WO2021222964A3 (fr) 2021-12-16

Family

ID=75953804

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2021/060160 WO2021222964A2 (fr) 2020-05-07 2021-05-07 Complexes immunogènes et leurs procédés de production et d'utilisation

Country Status (1)

Country Link
WO (1) WO2021222964A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041913A1 (fr) * 2000-11-27 2002-05-30 Jens Christian Jensenius Collectines utiles comme adjuvants
WO2017143024A2 (fr) * 2016-02-16 2017-08-24 President And Fellows Of Harvard College Vaccins contre des agents pathogènes et leurs procédés de production et d'utilisation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041913A1 (fr) * 2000-11-27 2002-05-30 Jens Christian Jensenius Collectines utiles comme adjuvants
WO2017143024A2 (fr) * 2016-02-16 2017-08-24 President And Fellows Of Harvard College Vaccins contre des agents pathogènes et leurs procédés de production et d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VALDIMARSSON H ET AL: "RECONSTITUTION OF OPSONIZING ACTIVITY BY INFUSION OF MANNAN-BINDINGLECTIN (MBL) TO MBL-DEFICIENT HUMANS", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, BLACKWELL SCIENCE PUBL., OXFORD, GB, vol. 48, no. 2, 1 August 1998 (1998-08-01), pages 116 - 123, XP000911946, ISSN: 0300-9475, DOI: 10.1046/J.1365-3083.1998.00396.X *

Also Published As

Publication number Publication date
WO2021222964A2 (fr) 2021-11-11

Similar Documents

Publication Publication Date Title
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
WO2021188969A3 (fr) Vaccins à coronavirus et procédés d'utilisation
WO2018190719A3 (fr) Anticorps anti-sirp alpha
WO2017191258A9 (fr) Vaccins contre l'arnm de la grippe
WO2016201049A3 (fr) Formulations de vaccins contre la néoplasie et méthodes de préparation de celles-ci
WO2019125011A3 (fr) Complexe d'administration transdermique utilisant une structure organométallique et de la nanocellulose
WO2017041100A3 (fr) Compositions vaccinales ayant une stabilité et une immunogénicité améliorées
NO20040258L (no) Preparat for behandling av negleinfeksjoner med nitrogenoksid
WO2006072348A3 (fr) Thiophene substitue par un alkinyle
EP4085131A4 (fr) Compositions immunogenes contre le sars-cov-2, leurs procèdes de fabrication et leur utilisation
WO2019241672A3 (fr) Variants de piline comp glycosylés, leurs procédés de fabrication et leurs utilisations
MX2020010178A (es) Composiciones para el peinado del cabello que comprenden poligalactomanos y un metodo para el uso de las mismas.
WO2016118040A8 (fr) Gels comprenant la nifédipine et le chlorure d'hydrogène de lidocaïne et son application et procédé de sa préparation à l'aide de nanotechnologies
WO2015066668A8 (fr) Procédé d'élimination d'alpha-galactose
WO2017145097A3 (fr) Conjugués d'acides aminés et de peptides et procédé de conjugaison
WO2019194773A3 (fr) Combinaison contenant de la linagliptine et de la metformine
WO2020127819A3 (fr) Composition pharmaceutique comprenant de l'apixaban
WO2011163486A3 (fr) Processus de façonnage ou de formage d'articles
MX2018005322A (es) Composicion dermocosmetica, proceso de produccion de la composicion topica, metodo para fortalecer la fragilidad de las uñas y uso de la composicion.
MX2023013004A (es) Composicion inmunogenica contra la influenza.
WO2021222964A3 (fr) Complexes immunogènes et leurs procédés de production et d'utilisation
WO2016157208A9 (fr) Vaccin basé sur le virus recombinant des oreillons jeryl lynn 2
EP4157290A4 (fr) Compositions, leurs utilisations en thérapie et leurs procédés
WO2018105941A3 (fr) Composition pour injection pour la prévention de chute des cheveux ou la stimulation de pousse des cheveux
WO2006102098A3 (fr) Immunogenes pour vaccins contre des pathogenes et maladies a antigenicite variable

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21726033

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21726033

Country of ref document: EP

Kind code of ref document: A2